This is because semaglutide continues to help control appetite and prevent overeating, even after the initial weight loss phase
Because while case reports link higher semaglutide doses to this painful skin sensitivity, other research shows GLP-1 receptor agonists actually reducing pain through anti-inflammatory mechanisms
Who must avoid it entirely in the class framing: anyone pregnant or breastfeeding, anyone with the personal/family MTC or MEN 2 history above, and anyone with prior serious hypersensitivity to a GLP-1 agonist
However, results vary, and individualized care is key to determining whether metabolic treatment, hormone therapy, or both offer the best outcome
It affects your dosing schedule, how long side effects last, and what happens when you discontinue treatment
Have been advised by your doctor not to use GLP-1 receptor agonists